Perbedaan Bank KB Bukopin Tbk dan Champion Pacific Indonesia Tbk.: Bank KB Bukopin Tbk diperdagangkan di Rp51 (kapitalisasi pasar 9,48 T, volume 24 jam 58,77 jt), sedangkan Champion Pacific Indonesia Tbk. diperdagangkan di Rp406 (kapitalisasi pasar 372,97 M, volume 24 jam 112,8 rb). Perbedaan utamanya: Bank KB Bukopin Tbk jauh lebih besar — sekitar 25,4× kapitalisasi pasar Champion Pacific Indonesia Tbk., dan Bank KB Bukopin Tbk lebih aktif diperdagangkan (58,77 jt vs 112,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BBKP | IGAR | |
|---|---|---|
Kapitalisasi Pasar | 9,48 T | 372,97 M |
Volume | 58,77 jt | 112,8 rb |
Lot | 587,74 rb | 1,13 rb |
Perputaran | 2,99 M | 47 jt |
Harga Rata-rata | 50,79 | 416,63 |
Nilai Transaksi | 2,99 M | 47 jt |
Harga Ekuilibrium Indikatif | 51 | 402 |
Volume Ekuilibrium Indikatif | 11,64 rb | 200 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bank Bukopin Tbk (the Bank) was established under its original name of Bank Umum Koperasi Indonesia (abbreviated to Bukopin) on Jul 10th, 1970 then changed to PT Bank Bukopin based on Notaries Deed dated Feb 25, 1993 and the deed of establishment was approved by the the Ministry of Justice dated June 29, 1993. The Bank started commercial operations as a limited liability company on July 1, 1993.
Selengkapnya di halaman BBKP →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Selengkapnya di halaman IGAR →